The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B
Open accessAbstract
Synucleinopathies, such as Parkinson's disease and dementia with Lewy bodies, are neurodegenerative disorders that are characterized by the accumulation of α-synuclein (aSyn) in intracellular inclusions known as Lewy bodies. Prefibrillar soluble aSyn oligomers, rather than larger inclusions, are currently considered to be crucial species underlying synaptic dysfunction. We identified the cellular prion protein (PrPC) as a key mediator in aSyn-induced synaptic impairment. The aSyn-associated impairment of long-term potentiation was blocked in Prnp null mice and rescued following PrPC blockade. We found that extracellular aSyn oligomers formed a complex with PrPC that induced the phosphorylation of Fyn kinase via metabotropic glutamate receptors 5 (mGluR5). aSyn engagement of PrPC and Fyn activated NMDA receptor (NMDAR) and altered calcium homeostasis. Blockade of mGluR5-evoked phosphorylation of NMDAR in aSyn transgenic mice rescued synaptic and cognitive deficits, supporting the hypothesis that a receptor-mediated mechanism, independent of pore formation and membrane leakage, is sufficient to trigger early synaptic damage induced by extracellular aSyn.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Larson, M., Sherman, M. A., Amar, F., Nuvolone, M., Schneider, J. A., Bennett, D. A., Aguzzi, A., & Lesné, S. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1858-12.2012 · Cited by 277
RetractedPlace navigation impaired in rats with hippocampal lesions
Morris, R. G. M., Garrud, P., Rawlins, J. N. P., & O'Keefe, J. (1982) · Nature · doi:10.1038/297681a0 · Cited by 6,340
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein
Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.-P., DeArmond, S. J., Prusiner, S. B., Aguet, M., & Weissmann, C. (1992) · Nature · doi:10.1038/356577a0 · Cited by 1,655
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560
Impaired Long-Term Potentiation, Spatial Learning, and Hippocampal Development in fyn Mutant Mice
Grant, S. G. N., O'Dell, T. J., Karl, K. A., Stein, P. L., Soriano, P., & Kandel, E. R. (1992) · Science · doi:10.1126/science.1361685 · Cited by 1,155
Prion protein is necessary for normal synaptic function
Collinge, J., Whittington, M. A., Sidle, K. C. L., Smith, C. J., Palmer, M. S., Clarke, A. R., & Jefferys, J. G. R. (1994) · Nature · doi:10.1038/370295a0 · Cited by 799
Src kinases: a hub for NMDA receptor regulation
Salter, M. W., & Kalia, L. V. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1368 · Cited by 776
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
Um, J. W., Nygaard, H. B., Heiss, J. K., Kostylev, M. A., Stagi, M., Vortmeyer, A., Wisniewski, T., Gunther, E. C., & Strittmatter, S. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3178 · Cited by 662
Schulz-Schaeffer, W. J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0711-0 · Cited by 627
Physiology of the prion protein
Linden, R., Martins, V. R., Prado, M. A. M., Cammarota, M., Izquierdo, I., & Brentani, R. R. (2008) · Physiological Reviews · doi:10.1152/physrev.00007.2007 · Cited by 617
Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.036 · Cited by 572
Cognitive status correlates with neuropathologic stage in Parkinson disease
Braak, H., Rüb, U., Jansen Steur, E. N. H., Del Tredici, K., & de Vos, R. A. I. (2005) · Neurology · doi:10.1212/01.wnl.0000158422.41380.82 · Cited by 560
Rockenstein, E., Mallory, M., Hashimoto, M., Song, D., Shults, C. W., Lang, I., & Masliah, E. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10231 · Cited by 502
Nakazawa, T., Komai, S., Tezuka, T., Hisatsune, C., Umemori, H., Semba, K., Mishina, M., Manabe, T., & Yamamoto, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008085200 · Cited by 466
Collins, M. O., Husi, H., Yu, L., Brandon, J. M., Anderson, C. N. G., Blackstock, W. P., Choudhary, J. S., & Grant, S. G. N. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03507.x · Cited by 440
Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
Gimbel, D. A., Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., & Strittmatter, S. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0395-10.2010 · Cited by 418
Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
Outeiro, T. F., Putcha, P., Tetzlaff, J. E., Spoelgen, R., Koker, M., Carvalho, F., Hyman, B. T., & McLean, P. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001867 · Cited by 401
Self-citationA Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice
Chesselet, M.-F., Richter, F., Zhu, C., Magen, I., Watson, M. B., & Subramaniam, S. R. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0104-2 · Cited by 346
Extracellular α-synuclein—a novel and crucial factor in Lewy body diseases
Lee, H.-J., Bae, E.-J., & Lee, S.-J. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.275 · Cited by 306
Histology of the Central Nervous System
Garman, R. H. (2011) · Toxicologic Pathology · doi:10.1177/0192623310389621 · Cited by 306
Alpha-synuclein: from secretion to dysfunction and death
Marques, O., & Outeiro, T. F. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.94 · Cited by 286
Self-citationPrion protein attenuates excitotoxicity by inhibiting NMDA receptors
Khosravani, H., Zhang, Y., Tsutsui, S., Hameed, S., Altier, C., Hamid, J., Chen, L., Villemaire, M., Ali, Z., Jirik, F. R., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711002 · Cited by 275
Diógenes, M. J., Dias, R. B., Rombo, D. M., Vicente Miranda, H., Maiolino, F., Guerreiro, P., Näsström, T., Franquelim, H. G., Oliveira, L. M. A., Castanho, M. A. R. B., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0234-12.2012 · Cited by 271
Self-citationThe biological function of the cellular prion protein: an update
Wulf, M.-A., Senatore, A., & Aguzzi, A. (2017) · BMC Biology · doi:10.1186/s12915-017-0375-5 · Cited by 265
Resenberger, U. K., Harmeier, A., Woerner, A. C., Goodman, J. L., Müller, V., Krishnan, R., Vabulas, R. M., Kretzschmar, H. A., Lindquist, S., Hartl, F. U., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.86 · Cited by 248
Evolutionary expansion and anatomical specialization of synapse proteome complexity
Emes, R. D., Pocklington, A. J., Anderson, C. N. G., Bayes, A., Collins, M. O., Vickers, C. A., Croning, M. D. R., Malik, B. R., Choudhary, J. S., Armstrong, J. D., et al. (2008) · Nature Neuroscience · doi:10.1038/nn.2135 · Cited by 196
Criado, J. R., Sánchez-Alavez, M., Conti, B., Giacchino, J. L., Wills, D. N., Henriksen, S. J., Race, R., Manson, J. C., Chesebro, B., & Oldstone, M. B. A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.001 · Cited by 189
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy
Laurent, C., Burnouf, S., Ferry, B., Batalha, V. L., Coelho, J. E., Baqi, Y., Malik, E., Mariciniak, E., Parrot, S., Van der Jeugd, A., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2014.151 · Cited by 188
Self-citationDi Scala, C., Yahi, N., Boutemeur, S., Flores, A., Rodriguez, L., Chahinian, H., & Fantini, J. (2016) · Scientific Reports · doi:10.1038/srep28781 · Cited by 186
Suzuki, T., & Okamuranoji, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2662 · Cited by 164
The spectrum of cognitive impairment in Lewy body diseases
Goldman, J. G., Williams‐Gray, C. H., Barker, R. A., Duda, J. E., & Galvin, J. E. (2014) · Movement Disorders · doi:10.1002/mds.25866 · Cited by 146
Batalha, V. L., Pego, J. M., Fontinha, B. M., Costenla, A. R., Valadas, J. S., Baqi, Y., Radjainia, H., Müller, C. E., Sebastião, A. M., & Lopes, L. V. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.8 · Cited by 136
Self-citationPedersen, W. A., Wan, R., Zhang, P., & Mattson, M. P. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00404.2002 · Cited by 135
Tebano, M. T., Martire, A., Rebola, N., Pepponi, R., Domenici, M. R., Grò, M. C., Schwarzschild, M. A., Chen, J., Cunha, R. A., & Popoli, P. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03455.x · Cited by 124
Membrane‐bound β‐amyloid oligomers are recruited into lipid rafts by a fyn‐dependent mechanism
Williamson, R., Usardi, A., Hanger, D. P., & Anderton, B. H. (2007) · The FASEB Journal · doi:10.1096/fj.07-9766com · Cited by 123
Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease
Um, J. W., & Strittmatter, S. M. (2013) · Prion · doi:10.4161/pri.22212 · Cited by 118
Martin, Z. S., Neugebauer, V., Dineley, K. T., Kayed, R., Zhang, W., Reese, L. C., & Taglialatela, G. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07576.x · Cited by 117
Cognitive deficits in a mouse model of pre‐manifest Parkinson’s disease
Magen, I., Fleming, S. M., Zhu, C., Garcia, E. C., Cardiff, K. M., Dinh, D., Rosa, K. D. L., Sánchez, M. Á., Torres, E. R. S., Masliah, E., et al. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08012.x · Cited by 110
Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety
Coelho, J. E., Alves, P., Canas, P. M., Valadas, J. S., Shmidt, T., Batalha, V. L., Ferreira, D. G., Ribeiro, J. A., Bader, M., Cunha, R. A., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00067 · Cited by 102
Self-citationAdenosine A2A receptor gene disruption protects in an α‐synuclein model of Parkinson's disease
Kachroo, A., & Schwarzschild, M. A. (2011) · Annals of Neurology · doi:10.1002/ana.22630 · Cited by 97
Adenosine A2AReceptors Modulate α-Synuclein Aggregation and Toxicity
Ferreira, D. G., Batalha, V. L., Miranda, H. V., Coelho, J. E., Gomes, R., Gonçalves, F. Q., Real, J. I., Rino, J., Albino‐Teixeira, A., Cunha, R. A., et al. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv268 · Cited by 95
Self-citationYang, M. J., Soohoo, D., Soelaiman, S., Kalla, R. V., Zablocki, J. A., Chu, N., Leung, K., Yao, L., Diamond, I., Belardinelli, L., et al. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0135-0 · Cited by 83
Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons
Urrea, L., Segura-Feliu, M., Masuda‐Suzukake, M., Hervera, A., Pedraz, L., García‐Aznar, J. M., Vila, M., Samitier, J., Torrents, E., Ferrer, I., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0451-4 · Cited by 79
Age-dependent loss of PTP and LTP in the hippocampus of PrP-null mice
Curtis, J. C., Errington, M. L., Bliss, T., Voss, K. L., & MacLeod, N. K. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00017-2 · Cited by 77
Caetano, F. A., Beraldo, F. H., Hajj, G. N. M., Guimaraes, A. L., Jürgensen, S., Wasilewska-Sampaio, A. P., Hirata, P. H. F., Souza, I., Machado, C. F., Wong, D. Y.-L., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07225.x · Cited by 74
Batalha, V. L., Ferreira, D. G., Coelho, J. E., Valadas, J. S., Gomes, R., Temido‐Ferreira, M., Shmidt, T., Baqi, Y., Buée, L., Müller, C. E., et al. (2016) · Scientific Reports · doi:10.1038/srep31493 · Cited by 70
Self-citationBeraldo, F. H., Ostapchenko, V. G., Caetano, F. A., Guimarães, A. L. S., Ferretti, G. D. S., Daude, N., Bertram, L. N., Nogueira, K. D. O. P. C., Silva, J. L., Westaway, D. A., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738286 · Cited by 67
Sarantis, K., Tsiamaki, E., Kouvaros, S., Papatheodoropoulos, C., & Angelatou, F. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13291 · Cited by 65
Twenty Years of Calcium Imaging: Cell Physiology to Dye For
Knot, H. J., Laher, I., Sobie, E. A., Guatimosim, S., Gomez-Viquez, L., Hartmann, H., Song, L.-S., Lederer, W. J., Graier, W. F., Malli, R., et al. (2005) · Molecular Interventions · doi:10.1124/mi.5.2.8 · Cited by 55
Synucleinopathies: common features and hippocampal manifestations
Yang, W., & Yu, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2411-y · Cited by 49
Schmitz, M., Greis, C. M., Ottis, P., Silva, C. J., Schulz‐Schaeffer, W., Wrede, A., Koppe, K., Onisko, B., Requena, J. R., Govindarajan, N., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8655-3 · Cited by 47
Self-citationIncreased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt–Jakob disease
Kasai, T., Tokuda, T., Ishii, R., Ishigami, N., Tsuboi, Y., Nakagawa, M., Mizuno, T., & El‐Agnaf, O. M. A. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7334-7 · Cited by 37
Valadas, J. S., Batalha, V. L., Ferreira, D. G., Gomes, R., Coelho, J. E., Sebastião, A. M., Diógenes, M. J., & Lopes, L. V. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12050 · Cited by 32
Self-citationThe prion protein constitutively controls neuronal store-operated Ca2+ entry through Fyn kinase
Mario, A. D., Castellani, A., Peggion, C., Massimino, M. L., Lim, D., Hill, A. F., Sorgato, M. C., & Bertoli, A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00416 · Cited by 28
Impaired Motor Coordination in Mice Lacking Prion Protein
Katamine, S., Nishida, N., Sugimoto, T., Noda, T., Sakaguchi, S., Shigematsu, K., Kataoka, Y., Nakatani, A., Hasegawa, S., Moriuchi, R., et al. (1998) · Cellular and Molecular Neurobiology · doi:10.1023/a:1020698305911 · Cited by 28
Gallily, R., Kipper‐Galperin, M., & Brenner, T. (1999) · Inflammation · doi:10.1023/a:1020234321879 · Cited by 27
Sorgato, M. C., & Bertoli, A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.026 · Cited by 22
Miranda, H. V., Xiang, W., de Oliveira, R. M., Simões, T., Pimentel, J., Klucken, J., Penque, D., & Outeiro, T. F. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12251 · Cited by 22
Self-citation
Cited by
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer’s Disease
Zhang, H., Wei, W., Zhao, M., Ma, L., Jiang, X., Pei, H., Cao, Y., & Li, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.57078 · Cited by 689
Dementia with Lewy bodies: an update and outlook
Outeiro, T. F., Koss, D. J., Erskine, D., Walker, L., Kurzawa-Akanbi, M., Burn, D., Donaghy, P., Morris, C., Taylor, J.-P., Thomas, A., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0306-8 · Cited by 381
Self-citationMeningeal γδ T cell-derived IL-17 controls synaptic plasticity and short-term memory
Ribeiro, M., Brigas, H. C., Temido-Ferreira, M., Pousinha, P. A., Regen, T., Santa, C., Coelho, J. E., Marques-Morgado, I., Valente, C. A., Omenetti, S., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aay5199 · Cited by 335
Self-citationPrions, prionoids and protein misfolding disorders
Scheckel, C., & Aguzzi, A. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0011-4 · Cited by 321
α-Synuclein strains target distinct brain regions and cell types
Lau, A., So, R. W. L., Lau, H. H. C., Sang, J. C., Ruiz-Riquelme, A., Fleck, S. C., Stuart, E., Menon, S., Visanji, N. P., Meisl, G., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-019-0541-x · Cited by 309
Metadata
- Authors
- Ferreira, D. G., Temido-Ferreira, M., Vicente Miranda, H., Batalha, V. L., Coelho, J. E., Szegö, É. M., Marques-Morgado, I., Vaz, S. H., Rhee, J. S., Schmitz, M., Zerr, I., Lopes, L. V., & Outeiro, T. F.
- Venue
- Nature Neuroscience
- Published
- 2017-09-25
- Volume
- 20
- Issue
- 11
- Pages
- 1569-1579
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2758608092
- Cited by
- 278
- References
- 59
- FWCI
- 17.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.